HRTX
Heron Therapeuti
0.2942$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 2.7% | 14.9% | 35.5% | 42.2% | 40.8% | 53.3% | 51.0% | 51.2% | 26.8% | 26.7% | |
| – | – | 97.3% | 85.1% | 64.5% | 57.8% | 59.2% | 46.7% | 49.0% | 48.8% | 73.2% | 73.3% | |
| – | – | 8,062.9% | 450.4% | 180.7% | 114.7% | 196.9% | 151.5% | 99.8% | 30.8% | 11.6% | 8.0% | |
| – | – | 1,670.5% | 83.1% | 37.8% | 26.0% | 47.6% | 46.5% | 34.8% | 46.0% | 37.0% | 35.3% | |
| – | – | 13,460.4% | 717.4% | 301.9% | 202.1% | 316.6% | 299.0% | 211.2% | 135.8% | 81.2% | 74.9% | |
| – | – | -13,363.2% | -632.4% | -237.4% | -144.3% | -257.4% | -252.3% | -162.2% | -87.1% | -8.0% | -1.6% | |
| – | – | 208.3% | 12.8% | 3.4% | 1.0% | 2.1% | 2.8% | 2.3% | 3.0% | 4.2% | 6.2% | |
| – | – | -13,537.4% | -641.9% | -230.8% | -140.3% | -256.4% | -255.6% | -169.1% | -87.0% | -9.4% | -13.0% | |
| – | – | -85.9% | 12.7% | 10.0% | 1.3% | -3.2% | -3.5% | -44.1% | 2.1% | – | – | |
| – | – | -13,537.4% | -641.9% | -230.8% | -140.3% | -253.2% | -252.1% | -124.9% | -87.0% | -9.4% | -13.0% | |
| – | – | -13,277.2% | -624.1% | -235.5% | -137.9% | -254.2% | -248.8% | -159.5% | -81.7% | -3.5% | -11.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.